Meeting News CoverageVideoFrom OSN Europe

VIDEO: Speaker — Early anti-VEGF treatment yields better final outcomes in CNV

FLORENCE, Italy — At the FLOREtina meeting, Young-Hee Yoon, MD, PhD, gives her views on when to start and how long to continue anti-VEGF treatment for myopic choroidal neovascularization. Based on 5-year follow-up data, Yoon addresses questions that were not resolved in pivotal trials.

FLORENCE, Italy — At the FLOREtina meeting, Young-Hee Yoon, MD, PhD, gives her views on when to start and how long to continue anti-VEGF treatment for myopic choroidal neovascularization. Based on 5-year follow-up data, Yoon addresses questions that were not resolved in pivotal trials.

    See more from FLORetina